WHO Director-General, Tedros Adhanom Ghebreyesus, addressing a virtual press conference, said that the WHO-backed trials had been “suspended while the safety is reviewed”.
The decision has been taken, after a publication indicated that the use of Chloroquine could increase the likelihood of dying.
“It’s important to continue to gather evidence on the efficacy and safety of hydroxychloroquine.
“We want to use it if it’s safe and efficacious, reduces mortality, reduces the length of hospitalization without increasing adverse events,” WHO Chief Scientist, Soumya Swaminathan, added at the press briefing in Geneva.
